Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg 20246, Germany.
BMC Psychiatry. 2014 Oct 14;14:286. doi: 10.1186/s12888-014-0286-8.
Despite considerable research on substance-abuse placement matching, evidence is still inconclusive. The aims of this exploratory trial are to evaluate (a) the effects of following matching guidelines on health-care costs and heavy drinking, and (b) factors affecting the implementation of matching guidelines in the treatment of alcohol-dependent patients.
A total of 286 alcohol-dependent patients entering one of four participating detoxification units and having no arrangements for further treatment will be recruited. During the first week of treatment, all patients will be administered Measurements in the Addictions for Triage and Evaluation (MATE), European Quality of Life-Five Dimensions health status questionnaire (EQ-5D), and the Client Socio--Demographic and Service Receipt Inventory-European Version (CSSRI-EU). Patients who are randomly allocated to the intervention group will receive feedback regarding their assessment results, including clear recommendations for subsequent treatment. Patients of the control group will receive treatment as usual and, if requested, global feedback regarding their assessment results, but no recommendations for subsequent treatment. At discharge, treatment outcome and referral decisions will be recorded. Six months after discharge, patients will be administered MATE-Outcome, EQ-5D, and CSSRI-EU during a telephone interview.
This trial will provide evidence on the effects and costs of using placement-matching guidelines based on a standardized assessment with structured feedback in the treatment of alcohol-dependent patients. A process evaluation will be conducted to facilitate better understanding of the relationship between the use of guidelines, outcomes, and potential mediating variables.
German Clinical Trials Register DRKS00005035. Registered 03 June 2013.
尽管已经有大量关于物质滥用患者安置匹配的研究，但目前的证据仍不明确。本探索性试验旨在评估：（a）遵循匹配指南对医疗成本和重度饮酒的影响；（b）影响酒精依赖患者治疗中匹配指南实施的因素。
将招募 286 名进入四个参与的戒毒单位且没有进一步治疗安排的酒精依赖患者。在治疗的第一周，所有患者将接受酒精使用障碍分诊评估量表（MATE）、欧洲生活质量五维度健康状况问卷（EQ-5D）和客户社会人口统计学和服务接收清单-欧洲版（CSSRI-EU）的测量。随机分配到干预组的患者将收到他们评估结果的反馈，包括对后续治疗的明确建议。对照组的患者将接受常规治疗，如果需要，他们将收到关于他们评估结果的全球反馈，但没有对后续治疗的建议。出院时，将记录治疗结果和转介决定。出院后 6 个月，患者将通过电话访谈接受 MATE-Outcome、EQ-5D 和 CSSRI-EU 的评估。
本试验将提供基于标准化评估和结构化反馈在酒精依赖患者治疗中使用安置匹配指南的效果和成本的证据。将进行过程评估，以更好地理解指南使用、结果和潜在中介变量之间的关系。
德国临床试验注册处 DRKS00005035。2013 年 6 月 3 日注册。
